Can Shorter Fluoroscopic Time Obviates the Need of Routine Heparin Use in Coronary Angiography via Femoral Route? A Prospective Study

Background: The use of heparin in coronary angiography (CAG) through radial route is a well-known practice. However, the prophylactic use of heparin following the femoral arterial sheath insertion is still controversial, so we aimed to assess the safety of CAG without the use of heparin through femo...

Full description

Bibliographic Details
Main Authors: Om Murti Anil, Nabin Chaudhary, Arun Sayami, Saheb Kumar Jayswal, Naresh Maharjan, Bhawani Manandhar, Paras Koirala, Ujit Kumar Karmacharya
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Journal of Clinical and Preventive Cardiology
Subjects:
Online Access:http://www.jcpconline.org/article.asp?issn=2250-3528;year=2019;volume=8;issue=4;spage=161;epage=165;aulast=Anil
id doaj-db340ba484064a0fa0b757a02661b9c2
record_format Article
spelling doaj-db340ba484064a0fa0b757a02661b9c22020-11-24T21:40:20ZengWolters Kluwer Medknow PublicationsJournal of Clinical and Preventive Cardiology2250-35282019-01-018416116510.4103/JCPC.JCPC_28_19Can Shorter Fluoroscopic Time Obviates the Need of Routine Heparin Use in Coronary Angiography via Femoral Route? A Prospective StudyOm Murti AnilNabin ChaudharyArun SayamiSaheb Kumar JayswalNaresh MaharjanBhawani ManandharParas KoiralaUjit Kumar KarmacharyaBackground: The use of heparin in coronary angiography (CAG) through radial route is a well-known practice. However, the prophylactic use of heparin following the femoral arterial sheath insertion is still controversial, so we aimed to assess the safety of CAG without the use of heparin through femoral approach by minimizing fluoroscopy time. Methods: All patients undergoing diagnostic CAG through femoral approach were enrolled in our study. Heparin was not given after femoral sheath insertion contrary to the usual practice. Depending on the fluoroscopy time, patients were divided into three groups: (a) group with fluoroscopy time <2 min, (b) group with fluoroscopy time 2–5 min, and (c) group with fluoroscopy time 5–10 min. The study patients were prospectively assessed for any thrombus formation or embolic event. Femoral puncture site and other complications were also studied simultaneously. Patients with primary/elective angioplasty and longer fluoroscopy time (>10 min) were excluded from the study as well as those who received heparin. Results: Altogether, 1550 patients were enrolled in the study over a period of 3 years. The mean age of the study population was 57.0 ± 12.5 years; 71% of the patients were male. Fluoroscopy time was <2 min in 63% of the patients, 2–5 min in 33% of the patients, and 4% of the patients had fluoroscopy time of 5–10 min. No thromboembolic clinical events were recorded in the entire population during the study. Femoral sheath thrombus was seen in only 2.9% of the patients, and all of these cases had a fluoroscopy time of ≥5 min. Conclusion: CAG can be safely performed through femoral route without the use of heparin and without any associated thromboembolic complications if fluoroscopy time is <10 min.http://www.jcpconline.org/article.asp?issn=2250-3528;year=2019;volume=8;issue=4;spage=161;epage=165;aulast=Anilcomplicationscoronary angiographyfemoral artery approachfluoroscopy timewithout heparin
collection DOAJ
language English
format Article
sources DOAJ
author Om Murti Anil
Nabin Chaudhary
Arun Sayami
Saheb Kumar Jayswal
Naresh Maharjan
Bhawani Manandhar
Paras Koirala
Ujit Kumar Karmacharya
spellingShingle Om Murti Anil
Nabin Chaudhary
Arun Sayami
Saheb Kumar Jayswal
Naresh Maharjan
Bhawani Manandhar
Paras Koirala
Ujit Kumar Karmacharya
Can Shorter Fluoroscopic Time Obviates the Need of Routine Heparin Use in Coronary Angiography via Femoral Route? A Prospective Study
Journal of Clinical and Preventive Cardiology
complications
coronary angiography
femoral artery approach
fluoroscopy time
without heparin
author_facet Om Murti Anil
Nabin Chaudhary
Arun Sayami
Saheb Kumar Jayswal
Naresh Maharjan
Bhawani Manandhar
Paras Koirala
Ujit Kumar Karmacharya
author_sort Om Murti Anil
title Can Shorter Fluoroscopic Time Obviates the Need of Routine Heparin Use in Coronary Angiography via Femoral Route? A Prospective Study
title_short Can Shorter Fluoroscopic Time Obviates the Need of Routine Heparin Use in Coronary Angiography via Femoral Route? A Prospective Study
title_full Can Shorter Fluoroscopic Time Obviates the Need of Routine Heparin Use in Coronary Angiography via Femoral Route? A Prospective Study
title_fullStr Can Shorter Fluoroscopic Time Obviates the Need of Routine Heparin Use in Coronary Angiography via Femoral Route? A Prospective Study
title_full_unstemmed Can Shorter Fluoroscopic Time Obviates the Need of Routine Heparin Use in Coronary Angiography via Femoral Route? A Prospective Study
title_sort can shorter fluoroscopic time obviates the need of routine heparin use in coronary angiography via femoral route? a prospective study
publisher Wolters Kluwer Medknow Publications
series Journal of Clinical and Preventive Cardiology
issn 2250-3528
publishDate 2019-01-01
description Background: The use of heparin in coronary angiography (CAG) through radial route is a well-known practice. However, the prophylactic use of heparin following the femoral arterial sheath insertion is still controversial, so we aimed to assess the safety of CAG without the use of heparin through femoral approach by minimizing fluoroscopy time. Methods: All patients undergoing diagnostic CAG through femoral approach were enrolled in our study. Heparin was not given after femoral sheath insertion contrary to the usual practice. Depending on the fluoroscopy time, patients were divided into three groups: (a) group with fluoroscopy time <2 min, (b) group with fluoroscopy time 2–5 min, and (c) group with fluoroscopy time 5–10 min. The study patients were prospectively assessed for any thrombus formation or embolic event. Femoral puncture site and other complications were also studied simultaneously. Patients with primary/elective angioplasty and longer fluoroscopy time (>10 min) were excluded from the study as well as those who received heparin. Results: Altogether, 1550 patients were enrolled in the study over a period of 3 years. The mean age of the study population was 57.0 ± 12.5 years; 71% of the patients were male. Fluoroscopy time was <2 min in 63% of the patients, 2–5 min in 33% of the patients, and 4% of the patients had fluoroscopy time of 5–10 min. No thromboembolic clinical events were recorded in the entire population during the study. Femoral sheath thrombus was seen in only 2.9% of the patients, and all of these cases had a fluoroscopy time of ≥5 min. Conclusion: CAG can be safely performed through femoral route without the use of heparin and without any associated thromboembolic complications if fluoroscopy time is <10 min.
topic complications
coronary angiography
femoral artery approach
fluoroscopy time
without heparin
url http://www.jcpconline.org/article.asp?issn=2250-3528;year=2019;volume=8;issue=4;spage=161;epage=165;aulast=Anil
work_keys_str_mv AT ommurtianil canshorterfluoroscopictimeobviatestheneedofroutineheparinuseincoronaryangiographyviafemoralrouteaprospectivestudy
AT nabinchaudhary canshorterfluoroscopictimeobviatestheneedofroutineheparinuseincoronaryangiographyviafemoralrouteaprospectivestudy
AT arunsayami canshorterfluoroscopictimeobviatestheneedofroutineheparinuseincoronaryangiographyviafemoralrouteaprospectivestudy
AT sahebkumarjayswal canshorterfluoroscopictimeobviatestheneedofroutineheparinuseincoronaryangiographyviafemoralrouteaprospectivestudy
AT nareshmaharjan canshorterfluoroscopictimeobviatestheneedofroutineheparinuseincoronaryangiographyviafemoralrouteaprospectivestudy
AT bhawanimanandhar canshorterfluoroscopictimeobviatestheneedofroutineheparinuseincoronaryangiographyviafemoralrouteaprospectivestudy
AT paraskoirala canshorterfluoroscopictimeobviatestheneedofroutineheparinuseincoronaryangiographyviafemoralrouteaprospectivestudy
AT ujitkumarkarmacharya canshorterfluoroscopictimeobviatestheneedofroutineheparinuseincoronaryangiographyviafemoralrouteaprospectivestudy
_version_ 1725926547354812416